BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16424897)

  • 1. Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue.
    Reis-Filho JS; Steele D; Di Palma S; Jones RL; Savage K; James M; Milanezi F; Schmitt FC; Ashworth A
    Mod Pathol; 2006 Feb; 19(2):307-19. PubMed ID: 16424897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells.
    Popnikolov NK; Cavone SM; Schultz PM; Garcia FU
    Mod Pathol; 2005 Dec; 18(12):1535-41. PubMed ID: 16258511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of c-kit in common benign and malignant breast lesions.
    Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
    Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer.
    Bryan BB; Schnitt SJ; Collins LC
    Mod Pathol; 2006 May; 19(5):617-21. PubMed ID: 16528377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathology of myoepithelial (basocellular) hyperplasias in adenosis and epitheliosis of the breast demonstrated by the reactivity of cytokeratins and S100 protein. An analysis of heterogenic cell proliferations in 90 cases of benign and malignant breast diseases.
    Bässler R; Katzer B
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):435-42. PubMed ID: 1280883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Basal and myoepithelial phenotype of metastatic mammary carcinomas. A prognostic factor in the palliative situation?].
    Mainka P; Kahlert S; Kirchner T; Mayr D; Diebold J
    Pathologe; 2008 Nov; 29 Suppl 2():363-9. PubMed ID: 18807040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile.
    Dabbs DJ; Chivukula M; Carter G; Bhargava R
    Mod Pathol; 2006 Nov; 19(11):1506-11. PubMed ID: 16941011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different proliferative activity of the glandular and myoepithelial lineages in benign proliferative and early malignant breast diseases.
    Bánkfalvi A; Ludwig A; De-Hesselle B; Buerger H; Buchwalow IB; Boecker W
    Mod Pathol; 2004 Sep; 17(9):1051-61. PubMed ID: 15254552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and significance of 14-3-3sigma, a novel myoepithelial marker, in normal, benign, and malignant breast tissue.
    Simpson PT; Gale T; Reis-Filho JS; Jones C; Parry S; Steele D; Cossu A; Budroni M; Palmieri G; Lakhani SR
    J Pathol; 2004 Mar; 202(3):274-85. PubMed ID: 14991892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study of TGF-alpha, TGF-beta1, EGFR, and IGF-1 expression in human breast carcinoma.
    Pilichowska M; Kimura N; Fujiwara H; Nagura H
    Mod Pathol; 1997 Oct; 10(10):969-75. PubMed ID: 9346175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.
    Livasy CA; Karaca G; Nanda R; Tretiakova MS; Olopade OI; Moore DT; Perou CM
    Mod Pathol; 2006 Feb; 19(2):264-71. PubMed ID: 16341146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistent lack of CD34-positive stromal cells in the stroma of malignant breast lesions.
    Kuroda N; Jin YL; Hamauzu T; Toi M; Miyazaki E; Hiroi M; Moriki T; Enzan H
    Histol Histopathol; 2005 Jul; 20(3):707-12. PubMed ID: 15944918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AlphaB-crystallin: a novel marker of invasive basal-like and metaplastic breast carcinomas.
    Sitterding SM; Wiseman WR; Schiller CL; Luan C; Chen F; Moyano JV; Watkin WG; Wiley EL; Cryns VL; Diaz LK
    Ann Diagn Pathol; 2008 Feb; 12(1):33-40. PubMed ID: 18164413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family.
    Abdel-Fatah TM; Powe DG; Hodi Z; Reis-Filho JS; Lee AH; Ellis IO
    Am J Surg Pathol; 2008 Apr; 32(4):513-23. PubMed ID: 18223478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries.
    Gould VE; Mosquera JM; Leykauf K; Gattuso P; Dürst M; Alonso A
    Hum Pathol; 2005 May; 36(5):536-45. PubMed ID: 15948121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas.
    Cimino-Mathews A; Subhawong AP; Elwood H; Warzecha HN; Sharma R; Park BH; Taube JM; Illei PB; Argani P
    Hum Pathol; 2013 Jun; 44(6):959-65. PubMed ID: 23260325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
    Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
    J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
    Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
    Zheng WQ; Looi LM; Cheah PL
    Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.